Concepedia

Mary Mackle

MM

Statistics

Publications

13

Citations

638

H-Index

12

Active since

2011

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Allergan (United States)

Forest Research Institute

Merck Biopharma Co., Ltd. (Japan)

Kennedy Krieger Institute

Mary Mackle is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in psychopharmacology, psychiatry, and psychiatric pharmacotherapy.

Publications per year

2011–2017

13

Publications

13

Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder

Robert L. Findling, Ronald L. Landbloom, Armin Szegedi et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2015 · 100 citations · Full text

, , +17

Asenapine as Adjunctive Treatment for Acute Mania Associated With Bipolar Disorder

Armin Szegedi, Joseph R. Calabrese, Mary Mackle et al. · Journal of Clinical Psychopharmacology · 2011 · 89 citations

, , +14

A Randomized Placebo-Controlled Trial of Asenapine for the Prevention of Relapse of Schizophrenia After Long-Term Treatment

John M. Kane, Mary Mackle, Linda Snow‐Adami et al. · The Journal of Clinical Psychiatry · 2011 · 80 citations

, , +17

Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder

Armin Szegedi, Suresh Durgam, Mary Mackle et al. · American Journal of Psychiatry · 2017 · 66 citations · Full text

, , +14

Effects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials

Armin Szegedi, Jun Zhao, Arjen van Willigenburg et al. · BMC Psychiatry · 2011 · 62 citations · Full text

, , +17

1–5 of 13